CliffBio

Sunovion

Patent cliffs & loss of exclusivity

Now Sunovion, is a pharmaceutical company dveloping central nervous system and respiratory therapies

Company

AngelList URLhttps://angel.co/sepracor
Legal NameSunovion Pharmaceuticals Inc.
Company Operating StatusActive
Contact Page URLhttps://www.sunovion.com/about-us/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/sunovion-pharmaceuticals
Facebook URLhttps://www.facebook.com/Sunovion/
Fax Number905-363-0162
Full Address500 Frank W Burr Blvd, Suite 550, Teaneck, NJ 07666

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. LATUDALURASIDONE HYDROCHLORIDESmall mol.Nov 2031
  2. LATUDALURASIDONE HYDROCHLORIDESmall mol.Nov 2031
  3. LATUDALURASIDONE HYDROCHLORIDESmall mol.Nov 2031
  4. LATUDALURASIDONE HYDROCHLORIDESmall mol.Nov 2031
  5. LATUDALURASIDONE HYDROCHLORIDESmall mol.Nov 2031

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.